Oropharyngeal surfactant can improve initial stabilisation and reduce rescue intubation in infants born below 25 weeks of gestation
Jazyk angličtina Země Norsko Médium print-electronic
Typ dokumentu klinické zkoušky kontrolované, časopisecké články
PubMed
28871620
DOI
10.1111/apa.14060
Knihovny.cz E-zdroje
- Klíčová slova
- Delivery room intubation, Oropharyngeal surfactant, Rescue intratracheal intubation, Threshold of viability,
- MeSH
- biologické přípravky aplikace a dávkování MeSH
- fosfolipidy aplikace a dávkování MeSH
- intratracheální intubace statistika a číselné údaje MeSH
- lidé MeSH
- novorozenci extrémně nezralí MeSH
- novorozenec MeSH
- plicní surfaktanty aplikace a dávkování MeSH
- resuscitace metody MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky kontrolované MeSH
- Názvy látek
- biologické přípravky MeSH
- fosfolipidy MeSH
- plicní surfaktanty MeSH
- poractant alfa MeSH Prohlížeč
AIM: Minimally aggressive and easily performed techniques that facilitate spontaneous respiratory stabilisation are required to reduce rescue intubation in extremely premature infants. This study evaluated the feasibility and safety of administering surfactant into the pharynx of infants born at <25 weeks immediately after birth. METHODS: This study of 19 infants was conducted from January 2013 to June 2014 in a tertiary perinatal centre in Prague. We administered 1.5 mL of Curosurf as a bolus into the pharynx and simultaneously performed a sustained inflation manoeuvre (SIM). The extent of the interventions, death and severe neonatal morbidity in the study group were compared with 20 controls born before the study period and 20 born after it. RESULTS: All infants received oropharyngeal surfactant within the median (interquartile range) time of 40 seconds (25-75) after cord camping. The surfactant had to be suctioned in one infant because of upper airway obstruction. Although more subsequent surfactant was administered in the study group, significantly fewer study period infants required intubation than the before and after controls (16% versus 75% and 58%, respectively, p < 0.01). CONCLUSION: Oropharyngeal surfactant with simultaneous SIM was feasible and safe and reduced the need for delivery room intubation in these fragile infants.
Citace poskytuje Crossref.org
Prophylactic Oropharyngeal Surfactant for Preterm Newborns at Birth: A Randomized Clinical Trial